AVANIR PHARMACEUTICALS, INC CL A
AVNR
AVNR was delisted on the 12th of January, 2015.
166 hedge funds and large institutions have $2.74B invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 45 increasing their positions, 42 reducing their positions, and 44 closing their positions.
129% more call options, than puts
Call options by funds: $54.8M | Put options by funds: $23.9M
57% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 44
42% more capital invested
Capital invested by funds: $1.93B → $2.74B (+$812M)
17% more funds holding
Funds holding: 142 → 166 (+24)
7% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 42
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$247M |
| 2 |
WIC
Water Island Capital
New York
|
+$74.7M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$56.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$53.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$219M |
| 2 |
JG
Jefferies Group
New York
|
-$79.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$64.5M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$64.2M |
| 5 |
Millennium Management
New York
|
-$47.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PI
201
Putnam Investments
Boston,
Massachusetts
| – | -$205K | -17,200 | Closed |
|
|
PM
202
Parametrica Management
Wanchai,
Hong Kong
| – | -$194K | -16,296 | Closed |
|
|
IHL
203
Investment House LLC
Redondo Beach,
California
| – | -$181K | -15,200 | Closed |
|
204
BNP Paribas Financial Markets
Paris,
France
| – | -$128K | -10,700 | Closed |
|
|
CSS
205
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$45K | -3,806 | Closed |
|
|
MAA
206
Managed Account Advisors
Jersey City,
New Jersey
| – | -$15K | -1,259 | Closed |
|
|
SFU
207
Stonehage Fleming (UK)
London,
United Kingdom
| – | -$14K | -1,167 | Closed |
|
|
VIA
208
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$12K | -1,000 | Closed |
|
|
IC
209
Intersect Capital
San Ramon,
California
| – | +$352 | +25 | New |
|
|
NFG
210
Next Financial Group
Houston,
Texas
| – | +$352 | +25 | New |
|
AVNR Hedge Fund Activity: Q4 2014 in Review
166 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q4 2014, worth a combined $2.74B — up 42% from $1.93B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new AVNR positions and 44 closed out — a net gain of 25 holders — while 45 added to existing stakes and 42 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $247M. The largest seller was Fidelity Investments, cutting an estimated $219M.
- 166 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q4 2014, up from 142 in Q3 2014.
- Funds reported $2.74B of AVANIR PHARMACEUTICALS, INC CL A stock for Q4 2014, up 42% quarter-over-quarter.
- 69 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q4 2014 and 44 closed out, a net change of +25 holders.
- The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q4 2014 was Baker Bros. Advisors, an estimated $247M added.
- The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q4 2014 was Fidelity Investments, an estimated $219M sold.
Based on aggregated 13F filings for Q4 2014.